US regulator calls for limits on use of Celebrex, Bextra
21205
WASHINGTON, Dec 23  - US regulators called Thursday for use of Pfizer&#39;s painkilling drugs Celebrex and Bextra to be limited, urging doctors to keep in mind indications of higher heart attack and stroke risks.
633767
Drugmaker Pfizer Inc. is in talks with  regulators over a likely change to arthritis drug Bextra's  label to warn doctors about the risk of a potentially deadly  skin reaction, the company said in a regulatory filing.
215788
One area physician wishes his patients would call to seek his advice before going cold turkey when it comes to three widely prescribed arthritis medications - Vioxx, Bextra and Celebrex.
172769
WASHINGTON - Doctors are advised to limit their use of anti-inflammatory drugs linked to a higher risk of heart attack and stroke, US regulators said Thursday.
606693
Doctors writing in a prominent medical  journal on Friday recommended that physicians stop prescribing  Pfizer Inc.'s Bextra painkiller, just as a large study found  the drugmaker's sister drug, Celebrex,  doubled risk of heart  attacks.
397851
The controversy over painkillers known as Cox-2 inhibitors like Vioxx, Celebrex and Bextra and major cardiovascular events has prompted a leading heart specialist to speak out.
446964
WASHINGTON (CBS.MW) -- The US Food and Drug Administration said on Thursday that Pfizer&#39;s new pain drug Bextra will carry a labeled warning about a risk of cardiac and blood-clotting problems.
181893
The U.S. Food and Drug  Administration on Thursday ordered the review of preventative  studies involving Pfizer Inc.'s painkillers Celebrex and  Bextra, in light of recent evidence they may increase the risk  of heart attack and stroke.
16125
The Food and Drug Administration yesterday ordered a review of all prevention studies involving drugs such as Celebrex and Bextra, which have been associated with increased risk of heart problems. The agency also urged the public to limit use of over-the-counter pain medications.
449178
US regulators warned yesterday of possible heart risks with Pfizer&#39;s Bextra, delivering another blow to popular pain drugs cox-2 inhibitors such as Vioxx, withdrawn from the market by Merck in September.
106310
The US Food and Drug Administration is considering further regulatory measures, including withdrawal from the market, of Pfizer&#39;s arthritis treatment Celebrex.
198889
WASHINGTON  - A group of physicians and  families called on US regulators Tuesday to warn the public  about a rare but potentially fatal set of skin reactions linked  to taking the painkiller ibuprofen.
189407
U.S. regulators have "serious concerns"  about painkilling drugs in the class known as COX-2 inhibitors  and are due to issue a new ruling on them within days, the  Financial Times reported on its Web site on Sunday.
665220
Scientists in the United States and Great Britain are calling for a fresh look at Celebrex and other medications similar to Vioxx, the heavily advertised arthritis drug pulled from the market last week after a study suggested it doubled the risk of heart attacks and strokes.
302680
Consumers are advised that all over-the-counter pain medications should be used only as the label directs. While Celebrex and Bextra remain on the market, Merck recently withdrew its COX-2 Vioxx because of the increased risk of cardiovascular events.
692821
The arthritis drug Bextra will begin carrying a warning on the label about possible heart and blood-clotting problems, the Food and Drug Administration said yesterday.
695784
Pfizer Inc.'s Bextra will come with a new warning about possible heart and blood clotting problems when the drug is used by patients who have just had heart bypass surgery, the U.S. Food and Drug Administration said on Thursday.